Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-001293

CHIEF EXECUTIVE OFFICER sold 4,544 shares at an average $44.90 ($204,007)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-07 Sale : show line 1 in the form 10b5-1 −2,142 $45.34 $97,118 286,232 D
2025-01-08 Sale : show line 2 in the form 10b5-1 −2,402 $44.50 $106,889 283,830 D
Open-market sales · 4,544 sh · avg $44.90 · $204,007
Loading xslF345X05/form4-01102025_050107.xml…